Anaconda BioMed is a pre-clinical stage medical device company focused on the development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke. The Company's product, ANCD Brain®, is a novel device intended to be used to restore blood flow in patients experiencing an acute ischemic stroke due to a large vessel neurovascular occlusion. The Device is indicated for thrombus removal by aspiration in intracranial arteries but it remains compatible and can be used in combination with other interventional devices.
|Employees (est.) (Feb 2019)||22||(+5%)|
Anaconda Biomed total Funding
Anaconda Biomed latest funding size
Time since last funding
|2 years ago|
Anaconda Biomed investors
|Ysios Capital, Omega Funds, Innogest Capital, Banco Sabadell|
Anaconda Biomed has 172 Twitter Followers. The number of followers has increased 0.9% month over month and increased 3.8% quarter over quarter
When was Anaconda Biomed founded?
Anaconda Biomed was founded in 2015.
How many employees does Anaconda Biomed have?
Anaconda Biomed has 22 employees.
Who are Anaconda Biomed competitors?
Competitors of Anaconda Biomed include Oticon, Scientific Industries and Sunset Healthcare Solutions.
Where are Anaconda Biomed offices?
Anaconda Biomed has an office in Barcelona.
How many offices does Anaconda Biomed have?
Anaconda Biomed has 1 office.